CKK, L., E, K., FG, G., CMI, K., J, P., G, A., . . . GJ, B. (2025). Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012-2020. Journal of clinical pharmacology, 65(8), 955. https://doi.org/10.1002/jcph.70016
Chicago Style (17th ed.) CitationCKK, Lee, Kwon E, Green FG, Kelley CMI, Pham J, Abulwerdi G, Samuels S, Green DJ, and Burckart GJ. "Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012-2020." Journal of Clinical Pharmacology 65, no. 8 (2025): 955. https://doi.org/10.1002/jcph.70016.
MLA (9th ed.) CitationCKK, Lee, et al. "Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012-2020." Journal of Clinical Pharmacology, vol. 65, no. 8, 2025, p. 955, https://doi.org/10.1002/jcph.70016.